Status:
COMPLETED
Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors
Lead Sponsor:
AshtaYoga, LLC
Collaborating Sponsors:
Columbia University
Swami Vivekananda Yoga Anusandhana Samsthana
Conditions:
Breast Cancer
Eligibility:
FEMALE
35-70 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the efficacy of sukshma vyayama joint loosening yoga in improving aromatase inhibitor-induced arthralgia in post-menopausal breast cancer survivors and seco...
Detailed Description
Cancer survival rates are improving in the United States but this increased survivorship is offset by persistent treatment related symptoms, particularly for post-menopausal breast cancer survivors tr...
Eligibility Criteria
Inclusion
- Postmenopausal breast cancer survivors undergoing treatment with aromatase inhibitor hormonal therapy with self-reported arthralgia
- Must have initiated anastrazole, exemestane, or letrozole within 30 days of baseline assessment
- 35-70 years old
- Must be available during the dates of the study and willing to participate in the study
- Must have access to computer, tablet or smart phone and Internet connection
- Must be a member of Facebook
- Eligible if their arthralgia started after initiation of an AI or if they had preexisting joint pain that was exacerbated by AI use
- English speaking
Exclusion
- Non English-speaking
- Physically unable to perform the intervention
Key Trial Info
Start Date :
September 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 19 2018
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04042870
Start Date
September 4 2018
End Date
October 19 2018
Last Update
August 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032